122 search results for: Clinical Management

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and <b>Clinical</b> <b>Management</b> for Patients with Uncontrolled and/or Severe CRSwNP
Rhinology
ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
expert video

Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP

View more
Assessment of Smell Loss in CRSwNP Interactive Infographic
Rhinology
Assessment of Smell Loss in CRSwNP Interactive Infographic
interactivity

Use this educational tool to explore the daily burden of loss of smell for patients with CRSwNP.

View more
<b>Clinical</b> Utility of Biomarkers in the <b>Management</b> of AD
Dermatology
Clinical Utility of Biomarkers in the Management of AD
expert video

Dr. Amy Paller discusses the clinical utility of TARC measurements in AD management at EADV 2025

View more
Pediatric Asthma Trajectory and <b>Clinical</b> Remission
Type 2 Inflammation
Pediatric Asthma Trajectory and Clinical Remission
expert video

Join Dr. Leonard Bacharier as he discusses the definition of clinical remission in pediatric asthma and how it can represent a potential target in pediatric asthma management.

View more
.
Congress
9
March
2024
Congress
The Benefits of Early Intervention in AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.

European Academy of Dermatology and Venereology (EADV) 2023 | Berlin
Congress
11
October
2023
Congress
European Academy of Dermatology and Venereology (EADV) 2023 | Berlin

ADVENT Symposia brought global experts together to explore the latest advances in pediatric atopic dermatitis (AD), the shared and unique drivers of AD, prurigo nodularis (PN), and chronic spontaneous urticaria (CSU), and the pathology and patient management of PN.

EAACI 2024 | On-Treatment <b>Clinical</b> Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​
Congress
31
May
2024
Congress
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.

EAACI 2024 Moving Beyond Control To On-Treatment <b>Clinical</b> Remission
Pulmonology
EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission
expert video

Watch Prof G. Walter Canonica discuss the need to move beyond disease control to clinical remission in asthma and CRSwNP.

View more
On-Treatment <b>Clinical</b> Remission in Asthma Patients Case Tool
Pulmonology
On-Treatment Clinical Remission in Asthma Patients Case Tool
interactivity

Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.

View more
Key Treatment Considerations for <b>Management</b> of Atopic Dermatitis in Children
Dermatology
Key Treatment Considerations for Management of Atopic Dermatitis in Children
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang reviews the key considerations for management of AD that is uncontrolled with topical therapies in children and the criteria to determine whether a patient is indicated for systemic therapy

View more
Both <b>Clinical</b> and Sub<b>clinical</b> Disease Control Are Important to Achieve Disease Modification in AD
Dermatology
Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr. Eric Simpson explains how both clinical and subclinical disease control are critical for achieving true disease modification in atopic dermatitis, emphasizing the role of biomarkers in predicting long-term outcomes and guiding treatment decisions.

View more